In article <t1toql$38sv9$53@news.freedyn.de>
<governor.swill@gmail.com> wrote:
>
> Start putting queers in jail for failing to control themselves and spreading a disease.
>

More than 10,000 Americans have now tested positive in the
monkeypox outbreak across the U.S., according to figures
published late Wednesday by the Centers for Disease Control and
Prevention, as federal health officials say they are still
racing to contain the virus.

Cases have been reported in every state but Wyoming while 15
states and the District of Columbia have reported more than a
hundred cases. The largest numbers are in New York, California
and Florida.

No U.S. deaths have so far been reported, out of the 12
monkeypox fatalities the World Health Organization has tallied
so far this year.

Health officials say the virus is mostly spreading through close
interactions between men who have sex with men, either through
direct skin-to-skin contact or shared linens like towels and
bedding.

However, the CDC has tallied at least 50 cases in people who
were female at birth, including at least one pregnant woman. A
handful of suspected infections have also been spotted in young
children, although health authorities recently said some may
have actually been false positives.

Federal health authorities have warned for weeks that they
expected the U.S. outbreak to accelerate through August,
especially as availability of testing ramped up, following the
course of some other European countries that saw cases swell
earlier in the year.

The U.S. has reported the most infections of any country in the
world since late July. The American sum of cases is now roughly
double the size of Spain, the European nation that had
previously reported the most cases ahead of Germany and the
United Kingdom.

The pace of new cases now appears to be slowing in some
countries abroad. When measured relative to the size of each
nation's population, the CDC's tally is still smaller than in
those European nations, though the accelerating U.S. outbreak
now appears on pace to eclipse those rates too.

For states with more than 25 cases, CDC officials recently
estimated that the pace of new monkeypox infections is doubling
every 8.6 days on average.

On Wednesday, 1,391 new cases were reported nationwide to the
CDC � the largest single-day increase so far. The first known
case in the current U.S. outbreak was reported in mid-May.

"We are still operating under a containment goal, although I
know many states are starting to wonder if we're shifting to
more of a mitigation phase right now, given that our case counts
are still rising rapidly," Jennifer McQuiston, the CDC's top
monkeypox official, told a group of the agency's outside
advisers on Tuesday.

That effort might get easier over the coming weeks, following a
move by the Food and Drug Administration this week to grant
emergency use authorization to a method of using smaller doses
of the Jynneos monkeypox vaccine that could effectively multiply
the U.S. supply of the shots.

By administering these smaller doses between the skin's layers,
instead of deeper into the arm, authorities say it may be
possible to vaccinate up to five times as many people with each
vial and still yield a "nearly identical" immune response.

However, the CDC has long warned there was limited data showing
how effective the Jynneos vaccine is at actually curbing
monkeypox disease and transmission � urging those vaccinated to
continue taking "steps to protect themselves from infection"
during the outbreak.

The agency has previously reported on a handful of reports of
reported breakthrough infections following at least one shot of
the two-dose Jynneos vaccine. Early data from France, where the
vaccine is branded as Imvanex, also tallied breakthrough
infections.

Local health officials caution it will take time for them to
ramp up the new "intradermal" approach to vaccinations, which
relies on different needles and procedures than the traditional
"subcutaneous" shot.

"We won't just sort of say 'start.' We will make sure people
will have updated provider agreements, updated training
requirements, all of this. And you know, our first call with the
CDC about this is on Friday, just to give you a sense that this
is a process. It's not, 'here's the EUA, go'," Dr. Allison
Arwady, Chicago's top health official.

Arwady, who is the vice chair of the Big Cities Health
Coalition, estimated that around the country it could take up to
three weeks for local health departments to begin the new dose-
sparing approach.

Citing limited supply, the CDC currently says it does not
encourage "mass vaccination for the general public or for all
sexually active people." Instead, the agency says shots should
be prioritized first for people with HIV, pregnant and very
young people, and others who are considered at high risk for
severe disease.

But with supply now growing in the wake of the FDA's move,
McQuiston said the CDC might soon move to expand eligibility for
the shots to broader groups of people.

Officials are also weighing use of the older ACAM2000 vaccine,
despite concerns that it carries some more side effects and
risks than Jynneos.

"There are millions of doses of ACAM2000 in the system. And some
of our modeling here at CDC suggests that it could play an
important role in bringing this outbreak to a close, if it was
used carefully," said McQuiston.

https://www.cbsnews.com/news/monkeypox-cases-10000-cdc-
containment-vaccine/?intcid=CNI-00-10aaa3a